Product NDC: | 60681-1001 |
Proprietary Name: | Pleo Ex |
Non Proprietary Name: | candida albicans, candida parapsilosis and penicillium roqueforti |
Active Ingredient(s): | 3; 3; 3 [HP_X]/1; [HP_X]/1; [HP_X]/1 & nbsp; candida albicans, candida parapsilosis and penicillium roqueforti |
Administration Route(s): | RECTAL |
Dosage Form(s): | SUPPOSITORY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60681-1001 |
Labeler Name: | Sanum Kehlbeck GmbH & Co. KG |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 19960319 |
Package NDC: | 60681-1001-1 |
Package Description: | 1 DOSE PACK in 1 CARTON (60681-1001-1) > 10 SUPPOSITORY in 1 DOSE PACK |
NDC Code | 60681-1001-1 |
Proprietary Name | Pleo Ex |
Package Description | 1 DOSE PACK in 1 CARTON (60681-1001-1) > 10 SUPPOSITORY in 1 DOSE PACK |
Product NDC | 60681-1001 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | candida albicans, candida parapsilosis and penicillium roqueforti |
Dosage Form Name | SUPPOSITORY |
Route Name | RECTAL |
Start Marketing Date | 19960319 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Sanum Kehlbeck GmbH & Co. KG |
Substance Name | CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI |
Strength Number | 3; 3; 3 |
Strength Unit | [HP_X]/1; [HP_X]/1; [HP_X]/1 |
Pharmaceutical Classes |